Regeneron Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
REGN
CUSIP
75886F107
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 1,336 91.3 M $57.8 B
2024 Q4 1,392 93.2 M $66.4 B
2024 Q3 1,460 100 M $104 B
2024 Q2 1,403 104 M $109 B
2024 Q1 1,391 103 M $99.0 B
2023 Q4 1,343 100 M $88.0 B
2023 Q3 1,247 91.2 M $75.0 B
2023 Q2 1,231 92.6 M $66.1 B
2023 Q1 1,255 99.1 M $76.1 B
2022 Q4 1,221 99.2 M $70.8 B
2022 Q3 1,148 93.4 M $64.3 B
2022 Q2 1,121 93.4 M $55.2 B
2022 Q1 1,156 92.9 M $64.8 B
2021 Q4 1,144 90.8 M $57.3 B
2021 Q3 1,078 90.3 M $54.4 B
2021 Q2 1,028 89.1 M $49.7 B
2021 Q1 974 89.7 M $42.4 B
2020 Q4 971 91.5 M $44.8 B
2020 Q3 968 92.4 M $51.8 B
2020 Q2 992 93.1 M $58.0 B
2020 Q1 885 76.1 M $37.1 B
2019 Q4 762 75.3 M $28.3 B
2019 Q3 691 74.5 M $20.6 B
2019 Q2 738 74.6 M $23.3 B
2019 Q1 782 74.1 M $30.4 B
2018 Q4 734 74.4 M $27.8 B
2018 Q3 720 75.2 M $30.4 B
2018 Q2 689 73.3 M $25.3 B
2018 Q1 688 73.6 M $25.3 B
2017 Q4 709 71.6 M $26.9 B
2017 Q3 673 72.4 M $32.4 B
2017 Q2 666 73.1 M $35.9 B
2017 Q1 642 72.3 M $28.0 B
2016 Q4 647 72.2 M $26.5 B
2016 Q3 615 73.6 M $29.6 B
2016 Q2 604 72.6 M $25.4 B
2016 Q1 595 79.7 M $26.2 B
2015 Q4 633 73.9 M $42.5 B
2015 Q3 608 75.4 M $37.1 B
2015 Q2 585 73.9 M $37.7 B
2015 Q1 544 73.1 M $33.0 B
2014 Q4 559 72.8 M $30.0 B
2014 Q3 508 71.7 M $27.9 B
2014 Q2 481 75.2 M $21.6 B
2014 Q1 488 73.5 M $22.3 B